The Competition Commission of India (CCI) is examining the Indian leg of the mega merger between Bayer and Monsanto. The proposed acquisition of Monsanto’s entire shareholding by Bayer globally, which brings together two global giants in the seeds and agro-chemical markets, is also being examined in the US and EU. There is opposition amongst the antitrust experts and economists for justifiable reasons, which need to be discussed publicly in India. CCI has invited public comments on the merger on January 7, 2018.
If approved, the merger will lead to tight oligopoly of three multinational giants, (ChemChina-Syngenta, Du Pont-Dow and now
Disclaimer: These are personal views of the writer. They do not necessarily reflect the opinion of www.business-standard.com or the Business Standard newspaper